Showing results (301-310 of 1,167) with videos related to

Sort By:
Pageof 117
Oncotargets and Therapy|October 30, 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestationZi-Jun Gong, Wei Guo, Yun-Fan Sun, et al.
Cell Death & Disease|September 30, 2016
miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signalingYang Liu, Dong-Li Liu, Li-Li Dong, et al.
BMC Medicine|November 2, 2017
Rapid diagnosis of new and relapse tuberculosis by quantification of a circulating antigen in HIV-infected adults in the Greater Houston metropolitan areaJia Fan, Hedong Zhang, Duc T Nguyen, et al.
Surgical Innovation|May 17, 2021
Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver DysfunctionNan Xiao, Xiao-Long Li, Xiao-Dong Zhu, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2003
Surgery for large primary liver cancer more than 10 cm in diameterXin-Da Zhou, Zhao-You Tang, Zeng-Chen Ma, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|April 25, 2012
[TNFα induced IL-8 production through p38 MAPK- NF-kB pathway in human hepatocellular carcinoma cells]Yao-hui Wang, Jing-lin Xia, Wei-min Wang, et al.
Annals of Surgical Oncology|March 28, 2012
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosisXin Yin, Bo-Heng Zhang, Shuang-Jian Qiu, et al.
Genes & Diseases|March 18, 2020
Corrigendum to "A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance" [Genes Dis 694 (2019) 419-430]Wei Wang, Bo Hu, Jiang-Jiang Qin, et al.
Discover Oncology|August 18, 2025
Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinomaYue Wang, Pengxiang Wang, Hui Liu, et al.
Cell Reports. Medicine|August 6, 2025
Computational framework for prioritizing candidate compounds overcoming the resistance of pancancer immunotherapyFangyoumin Feng, Tian He, Ping Lin, et al.
Pageof 117